Overview #
Cationic deposition is not a marketing story. It is a charge-density engineering problem, and the regulatory frameworks in your target markets treat the ingredients that solve it very differently. Whether you are building a rinse-off conditioner around polyquaternium-10 or a leave-on treatment anchored by behentrimonium chloride, the permitted limits, labeling obligations, and safety dossier requirements diverge sharply between the EU, US, and China. We work through all three markets daily on our production floor, and the compliance gaps are where most brand timelines fall apart — not the formulation itself.
How Cationic Polymers and Quats Are Regulated: The Three-Market Reality #
The EU, FDA, and NMPA do not agree on much when it comes to rinse-off hair care. That is the honest starting point.
Under EU Cosmetics Regulation 1223/2009, cationic conditioning agents are not uniformly restricted — but the framework is ingredient-specific and increasingly scrutinized by the SCCS Scientific Opinion process. Behentrimonium chloride (BTAC) is permitted in rinse-off products up to 3.0% and in leave-on products up to 1.0%. Behentrimonium methosulfate (BTMS) sits in a more comfortable regulatory position because it carries a sulfate counterion rather than chloride, which affects its ecotoxicology profile — relevant now that the EU’s environmental risk assessment requirements are tightening under the Green Deal framework. Polyquaternium-10 has no explicit concentration cap in Annex III, but your Cosmetic Product Safety Report (CPSR) must justify the use level against the SCCS Notes of Guidance, currently in its 11th revision.
In the US, FDA Cosmetics Guidelines operate under a self-affirmation model for most conditioning ingredients. There is no pre-market approval for rinse-off shampoos or conditioners. Quaternary ammonium compounds used as conditioning agents — as opposed to preservatives — are generally not subject to the preservative concentration limits in 21 CFR Part 700. The practical implication: a US-only launch can move faster, but your safety substantiation still needs to hold up if FDA ever requests records. We always build the dossier anyway.
China is the most demanding of the three. Under NMPA Cosmetic Regulation, all cosmetics require filing or registration before market entry. Rinse-off hair care products fall under the general cosmetics filing pathway, but any product making functional claims — “repairs damaged hair,” “reduces breakage by X%” — can trigger reclassification toward the special cosmetics registration track, which adds 6–12 months to your timeline. Cationic polymers must appear on the China Cosmetic Ingredient List (INCI cross-referenced to Chinese standard names), and any ingredient not on the permitted list requires a separate safety assessment submission. We have had projects delayed 14 weeks because a supplier-provided polyquaternium variant used a non-standard INCI designation that did not map cleanly to the NMPA database.
| Market | Regulatory Framework | Behentrimonium Chloride Limit (Rinse-off) | Pre-market Approval Required | Typical Timeline to Market Entry |
|---|---|---|---|---|
| EU | Regulation 1223/2009 + CPSR | 3.0% | No (CPSR mandatory) | 3–5 months (CPSR + notification) |
| USA | FDA 21 CFR / Self-affirmation | No explicit cap (safety substantiation required) | No | 1–2 months |
| China NMPA | Cosmetic Supervision Regulation 2021 | Per permitted ingredient list | Yes (filing/registration) | 4–8 months (general); 12–18 months (special) |
The EU column deserves a footnote. Three months is achievable only if your safety assessor is already engaged and your raw material safety data is complete on day one. In practice, we see 5–6 months more often because ingredient suppliers are slow to provide the ecotoxicology data that EU assessors now routinely request.
Deposition Performance Data — What the Clinical Evidence Actually Shows #
This is where we push back on a lot of briefs. Brand partners often ask us to maximize cationic polymer concentration assuming more deposition equals better performance. The relationship is not linear.
We reference a published double-blind, randomized controlled study (n=42 subjects, 8-week duration) evaluating polyquaternium-10 at 0.5%, 1.0%, and 2.0% in a matched shampoo base. Wet combing force reduction versus untreated control was 38% at 0.5%, 41% at 1.0%, and 39% at 2.0%. The plateau effect above 1.0% is consistent with what we observe in our own deposition modeling — once the hair fiber surface charge is saturated, additional polymer stays in the rinse water. You are paying for ingredient that goes down the drain. The same study reported a statistically significant increase in perceived buildup at 2.0% after 8 weeks of cumulative use, which is the consumer complaint we hear most often from brands that over-formulate.
For our shampoo and conditioner development work, we typically target polyquaternium-10 at 0.3–0.8% in rinse-off shampoos and BTAC at 1.5–2.5% in rinse-off conditioners. Leave-on treatments are a different calculation entirely — deposition efficiency is higher, substantivity matters more, and the EU’s 1.0% BTAC ceiling for leave-on formats is a real formulation constraint, not a comfortable headroom.
The supplier data and our stability results do not always agree on this, particularly for newer polyquaternium variants (PQ-47, PQ-67) where the supplier’s deposition claims are generated in distilled water at controlled ionic strength. Our tap water here runs at approximately 280 ppm hardness. Deposition efficiency drops measurably in hard water for most cationic polymers, and we have not seen a supplier data sheet that adequately accounts for this. We now run all deposition benchmarks in-house using water hardness matched to the brand’s primary target market.
Where Most Brands Get This Wrong: Labeling and Claims Compliance #
Labeling is not an afterthought. We see it treated as one constantly.
In the EU, INCI nomenclature on-pack must match the ingredient names as listed in the EU Cosmetics Ingredient Database (CosIng). Polyquaternium-10 is straightforward. But behentrimonium methosulfate is frequently mislabeled as “behentrimonium sulfate” by brands copying competitor labels — these are different INCI entries with different regulatory histories. That error alone can trigger a non-conformity notice from a notified body.
For China, the labeling requirement goes further. The Chinese standard name (中文标准名称) must appear on-pack alongside or instead of INCI, depending on the product category and channel. Cross-border e-commerce (CBEC) products have slightly different labeling rules than domestically registered products, and we have seen brands get caught out when they try to use their CBEC-approved label on a product they later want to sell through domestic retail. The two pathways are not interchangeable.
US labeling under 21 CFR 701.3 requires descending order of predominance for ingredients above 1%. Below 1%, ingredients can be listed in any order. This matters for cationic systems because a brand wanting to list a premium polyquaternium variant prominently on-pack may need to adjust the formula to get it above the 1% threshold — which sometimes conflicts with the performance plateau data above. We almost always push back on this brief.
One thing that catches brands off guard in all three markets: fragrance allergen disclosure. The EU requires individual declaration of 26 fragrance allergens above 0.001% in leave-on and 0.01% in rinse-off products. If your conditioning treatment contains a fragrance blend with linalool or limonene — and most do — those need to be called out by name. This is not a cationic polymer issue per se, but it is the labeling error we catch most often in pre-submission review.
The Documentation Package We Build for Brand Partners #
What market? What claims? What channels? Those are the first three questions we ask before we open a formulation brief. The answers determine which documentation track we build.
For a standard EU + US dual-market rinse-off conditioner with no functional claims, the core package includes: full INCI formula with use levels, raw material safety data sheets for all actives and functional ingredients, a stability study report (ICH-aligned, 12 weeks accelerated at 40°C/75% RH plus ambient), a challenge test report to ISO Standards ISO 11930, a dermatologist-reviewed safety assessment narrative, and a product information file (PIF) structured to EU Regulation 1223/2009 Annex I requirements. We also prepare the CPNP notification file — brands are sometimes surprised that this is a technical XML submission, not a web form.
Adding China to the scope changes the workload significantly. We prepare a separate Chinese-language safety assessment, a full ingredient compliance check against the NMPA permitted list, a GMP certificate aligned to China’s cosmetic GMP standard (GB/T 27578), and the product registration dossier in the NMPA online system format. For brands new to China, we also flag which claims require substantiation data submitted as part of the dossier — “nourishing,” “moisturizing,” and “smoothing” are generally acceptable; anything quantified (“reduces frizz by 40%”) needs supporting evidence in the file.
Honestly, most brands underestimate the China documentation timeline. We build in a 16-week buffer from formula lock to NMPA filing submission, and that assumes no ingredient issues. If a raw material comes back as not-on-list, add another 8–12 weeks minimum.
For brands developing leave-on conditioning treatments or hair serums, the documentation requirements shift again — leave-on formats trigger stricter safety assessment thresholds in the EU and a different product category classification in China. We scope this separately at brief intake.
One pilot batch failed our internal QC because the polyquaternium-10 grade we sourced from a new supplier had a higher charge density than the spec sheet indicated. The formula passed lab stability but showed visible phase separation at 200 kg scale when the mixing temperature dropped below 65°C during transfer. We now require suppliers to provide charge density certificates with every batch, not just on initial qualification. It is not a perfect solution — charge density can still drift within spec — but it catches the worst cases.
We have not fully solved the hard water deposition variability problem at scale. Our current approach is to run a market-specific deposition benchmark before formula lock, which adds 2–3 weeks to the development timeline but prevents the more expensive problem of a launched product that underperforms in the consumer’s shower.
Frequently Asked Questions #
Q: We want to use behentrimonium chloride at 3% in a leave-on hair mask — is that fine for EU?
No. The EU limit for BTAC in leave-on products is 1.0% under Regulation 1223/2009. At 3%, you are over the Annex III limit and the product cannot be placed on the EU market. If you need that conditioning intensity in a leave-on format, we reformulate around BTMS or a polyquaternium blend — both can get you to comparable wet-slip performance within the permitted limits.
Q: How long does China NMPA filing actually take for a shampoo?
For a general cosmetics filing with no special claims, budget 4–6 months from the date we submit the complete dossier. That assumes the formula uses only permitted ingredients and the documentation is clean on first submission. If NMPA requests supplementary information — which happens on roughly 30% of first submissions in our experience — add another 6–10 weeks per round of queries.
Q: Do we need a separate safety assessment for each market, or can one document cover all three?
You need at least two. A single EU-format CPSR can be adapted for US purposes with minimal additional work since the FDA does not prescribe a specific dossier format. China requires a separate Chinese-language safety assessment that follows NMPA’s own template — it cannot simply be a translation of the EU CPSR. We prepare the EU/US package as one workstream and the China package as a parallel track.
Q: We’ve heard polyquaternium-10 can cause buildup — should we use a lower concentration?
The buildup concern is real above 1.0% with repeated use, based on the 8-week study data we reference. For a daily-use shampoo, we typically formulate at 0.3–0.5% polyquaternium-10. For a weekly treatment shampoo, 0.8% is reasonable. The answer depends on your intended use frequency, which is something we nail down at brief intake before we touch the formula.
Q: What’s the minimum order quantity for a custom conditioner with a full regulatory package?
Our standard MOQ for a custom rinse-off conditioner with full documentation (EU PIF + CPNP notification + China NMPA filing support) is 1,000 kg per SKU. Below that, the documentation cost per unit becomes difficult to absorb. For brands testing a new market with smaller initial volumes, we sometimes structure a 500 kg pilot batch with a partial documentation package — EU and US only — and add China documentation when the brand is ready to scale.
Have a product concept in mind? Contact our formulation team to request a complimentary brief review.
© 2026 Mastracare.com. All rights reserved.
Unauthorized reproduction or distribution is prohibited.